ARALEZ PHARMACEUTICALS INC. Proceeds from Common Stock Issued
ARALEZ PHARMACEUTICALS INC. reported Proceeds from Common Stock Issued of $75.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2018-03-14
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2016-03-31 was $75.00M, a 26215.79% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2016 was $75.00M, a 4222.77% increase from fiscal 2015.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2015 was $1.74M, a 77.14% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2014 was $7.59M.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $0.00 derived: sum of 3 quarters · filed 2018-03-14 | $75.00M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $75.00M 10-Q · filed 2017-11-09 | $75.05M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $75.00M 10-Q · filed 2017-08-09 | $75.05M derived: sum of 3 quarters · filed 2017-08-09 | $75.14M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-03-31 | $75.00M 10-Q · filed 2017-05-09 | $75.05M derived: sum of 2 quarters · filed 2017-05-09 | $75.14M derived: sum of 3 quarters · filed 2017-05-09 | $76.45M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2016-02-05 | $75.00M 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $138.00K derived: sum of 2 quarters · filed 2017-03-13 | $1.45M derived: sum of 3 quarters · filed 2017-03-13 | $1.74M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.40M derived: sum of 2 quarters · filed 2016-11-08 | $1.68M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.60M 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $285.00K 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | $7.59M 10-K · filed 2017-03-13 |